---
title: "Singapore Institute of Advanced Medicine Holdings Ltd. (9G2.SG)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/9G2.SG.md"
symbol: "9G2.SG"
name: "Singapore Institute of Advanced Medicine Holdings Ltd."
industry: "Health Care Services"
datetime: "2026-05-20T05:34:08.203Z"
locales:
  - [en](https://longbridge.com/en/quote/9G2.SG.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/9G2.SG.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/9G2.SG.md)
---

# Singapore Institute of Advanced Medicine Holdings Ltd. (9G2.SG)

## Company Overview

Singapore Institute of Advanced Medicine Holdings Ltd., an investment holding company, provides medical diagnostics and treatments, and radiation therapy and medical oncology services in Singapore. The company offers medical diagnostics and treatments, including cancer-related diagnostics and theragnostic treatments, general diagnostics and health screening, and aesthetic services; and radiation therapy and medical oncology services comprise proton beam therapy, photon radiation therapy, and medical oncology services. It provides clinic and imaging services; manufactures medical research and clinical diagnostic instruments and supplies; and sells pharmaceuticals, surgical products, and consumables. Singapore Institute of Advanced Medicine Holdings Ltd.

| Item | Detail |
|------|--------|
| Industry | Health Care Services |
| Exchange | SG Market |
| Website | [www.advancedmedicine.sg](https://www.advancedmedicine.sg) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: D
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:13.000Z

**Overall: D (0.73)**

**Industry**: Health Care Services

| Metric | Value |
|--------|-------|
| Industry Ranking | 14 / 15 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: D

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -2.22% |  |
| Net Profit YoY | 8.82% |  |
| P/B Ratio | 1.28 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 56823779.99 |  |
| Revenue | 15617107.22 |  |

#### Multi Score Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -51.03% | E |
| Profit Margin | -163.78% | E |
| Gross Margin | 41.47% | B |
| Revenue YoY | -2.22% | D |
| Net Profit YoY | 8.82% | C |
| Total Assets YoY | -1.94% | D |
| Net Assets YoY | -20.42% | E |
| Cash Flow Margin | 7.78% | D |
| OCF YoY | -2.22% | D |
| Turnover | 0.13 | E |
| Gearing Ratio | 63.80% | D |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Singapore Institute of Advanced Medicine Holdings Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-2.22%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "8.82%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "1.28",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "56823779.99",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "15617107.22",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "D",
      "indicators": [
        {
          "name": "ROE",
          "value": "-51.03%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-163.78%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "41.47%",
          "rating": "B"
        },
        {
          "name": "Revenue YoY",
          "value": "-2.22%",
          "rating": "D"
        },
        {
          "name": "Net Profit YoY",
          "value": "8.82%",
          "rating": "C"
        },
        {
          "name": "Total Assets YoY",
          "value": "-1.94%",
          "rating": "D"
        },
        {
          "name": "Net Assets YoY",
          "value": "-20.42%",
          "rating": "E"
        },
        {
          "name": "Cash Flow Margin",
          "value": "7.78%",
          "rating": "D"
        },
        {
          "name": "OCF YoY",
          "value": "-2.22%",
          "rating": "D"
        },
        {
          "name": "Turnover",
          "value": "0.13",
          "rating": "E"
        },
        {
          "name": "Gearing Ratio",
          "value": "63.80%",
          "rating": "D"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -2.22 | 9/15 | - | - | - |
| PB | 1.28 | 5/15 | 1.26 | 0.99 | 0.47 |
| PS (TTM) | 3.64 | 10/15 | 4.39 | 3.17 | 1.99 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | HC Surgical (1B1.SG) | A | C | B | A | C | B |
| 02 | Alliance HC (MIJ.SG) | B | B | A | D | B | B |
| 03 | Medinex (OTX.SG) | A | C | B | A | C | B |
| 04 | AsiaMedic (505.SG) | B | B | B | D | B | B |
| 05 | Livingstone Health (PRH.SG) | B | B | A | D | A | B |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/9G2.SG/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/9G2.SG/norm.md)
- [Related News](https://longbridge.com/en/quote/9G2.SG/news.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**